PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 14, 2024Infection and Immunity2 citationsOpen Access

Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform

View Full Paper
NKNittaya KhakhumNBNoe Baruch‐TorresJSJacob L. Stockton

Key Points

Key points are not available for this paper at this time.

Abstract

ABSTRACT Virus-like particles (VLPs) are protein-based nanoparticles frequently used as carriers in conjugate vaccine platforms. VLPs have been used to display foreign antigens for vaccination and to deliver immunotherapy against diseases. Hemolysin-coregulated proteins 1 (Hcp1) is a protein component of the Burkholderia type 6 secretion system, which participates in intracellular invasion and dissemination. This protein has been reported as a protective antigen and is used in multiple vaccine candidates with various platforms against melioidosis, a severe infectious disease caused by the intracellular pathogen Burkholderia pseudomallei . In this study, we used P22 VLPs as a surface platform for decoration with Hcp1 using chemical conjugation. C57BL/6 mice were intranasally immunized with three doses of either PBS, VLPs, or conjugated Hcp1-VLPs. Immunization with Hcp1-VLPs formulation induced Hcp1-specific IgG, IgG 1 , IgG 2c , and IgA antibody responses. Furthermore, the serum from Hcp1-VLPs immunized mice enhanced the bacterial uptake and opsonophagocytosis by macrophages in the presence of complement. This study demonstrated an alternative strategy to develop a VLPs-based vaccine platform against Burkholderia species.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Khakhum et al. (2024) studied this question.

synapsesocial.com/papers/68e792d4b6db643587704363https://doi.org/10.1128/iai.00019-24
Ask AI
Helpful
Bookmark
Share
View Full Paper